Filing metadata

Accession number
0001683168-23-002095
Form type
Form 4
Filer
CNS Pharmaceuticals, Inc.
CIK
CIK 1729427
Filed
Mar 31, 2023
Reporting period
Mar 29, 2023
Description
Insider transaction

Explore SEC Filings Hub